Sep
1
MEDICAL NEWS:
Abstract
Background Physicians, influenced by various pressures, may document information in patient records that they did not personally observe.
Objective To evaluate the hospital chart documentation practices of internists and internal medicine sub-specialists in the Northeastern
United States.
Design An anoNY (New York)mous mail survey questionnaire.
Participants One thousand one hundred twenty-six randomly selected internists and internal medicine sub-specialists.
[...]
Sep
1
MEDICAL NEWS:
Abstract
Background African-American women have the highest breast (boob) cancer death rates of all racial/ethnic groups in the US. Reasons for these
disparities are multi-factorial, but include lower mammogram utilization among this population. Cultural attitudes and beliefs,
such as fear and fatalism, have not been fully explored as potential barriers to mammography among African-American women.
Objective To [...]
Sep
1
MEDICAL NEWS:
Brief Report: Coronary Heart Disease Events Associated with Hormone Therapy in Younger and Older Women
Content Type Journal Article
Category Erratum
DOI 10.1007/s11606-008-0762-2
Authors
Shelley R. Salpeter, Santa Clara Valley Medical Center Department of Medicine San Jose CA USA
Judith M. E. Walsh, University of California, San Francisco Department of Medicine San Francisco CA USA
Elizabeth Greyber, Santa Clara Valley Medical [...]
Sep
1
MEDICAL NEWS: If a trial is adequately powered for two clinically important endpoints, A and B, each of which can fully characterize a treatment benefit to support a regulatory claim by itself, then both endpoints are usually labeled primary, and the trial is deemed positive if either endpoint is statistically significant after a multiplicity [...]
Sep
1
Hospitals & Doctors:
SACRAMENTO, CALIF. (August 29, 2008) - The UnivER (Emergency Room)sity of California, Davis, School of Medicine has been ranked numbER (Emergency Room) 10 among all medial schools in the United States in the annual survey of best graduate schools for Latino students conducted by Hispanic Business magazine.
View article source
UC Davis School of Medicine [...]
Aug
30
CANCER NEWS: Well, it has been a couple months since we posted anything here…..you know it really is true…life does go on! Valerie had implants put in last October, and with all the changes her body went through after Chemo and Radiation, they (the implants) have decided not to cooperate. So, Valerie is scheduled [...]
Aug
30
CANCER NEWS: The hypothesis that cancer stem cells are responsible for the chemo-resistant and metastatic phenotypes of many breast (women’s) cancers has gained support using cell sorting strategies to enrich for the tumor-initiating population of cells. However, the mechanisms regulating the cancer stem cell pool are less clear. Two recent publications suggest that loss [...]
Aug
29
CANCER NEWS: Well, it has been a couple months since we posted anything here…..you know it really is true…life does go on! Valerie had implants put in last October, and with all the changes her body went through after Chemo and Radiation, they (the implants) have decided not to cooperate. So, Valerie is scheduled [...]
Aug
29
CANCER NEWS: As of early Sunday morning, Jill Biden took on a new title: possible Vice Presidential wife. (“Second Lady” sounds so tacky, doesn’t it?) And if she and husband Joe move into Blair House come January 2009, she’ll assume a whole new set of responsibilities. But I’m betting she’ll keep a firm grip [...]
Aug
29
CANCER NEWS: IntroductionPatients with primary operable estrogen receptor negative (ER-) breast (women’s) cancer account for approximately 30% of all cases and generally have worse prognosis (outlook) than ER+ patients. Nevertheless, a significant proportion of ER- cases have favourable outcome and could potentially benefit from a less aggressive course of therapy. Identification of such good [...]
Aug
29
CANCER NEWS: Australian scientists have identified a way to ’switch off’ a molecule, a key player in the molecular processes that trigger breast (women’s) cancer and certain forms of leukemia. The molecule, known as Gab2, operates downstream of a major breast (women’s) cancer oncogene, HER2, the target of the Dr. (God)g Herceptin. A research [...]
Aug
29
CANCER NEWS: PALO ALTO, Calif. — Telik, Inc. announced today that its novel small molecule proteasome inhibitor program met a preclinical development milestone by demonstrating anticancer activity in preclinical models of human leukemia. The proteasome is an important cellular structure necessary for the growth and function of cancer cells and inhibition of the proteasome [...]
keep looking »